Cargando…

Messenger ribonucleic acid vaccines for severe acute respiratory syndrome coronavirus-2 – a review

The mRNA therapeutics have been studied since the 1970s and the currently available mRNA vaccines against COVID-19 are the culmination of decades of scientific research. The mRNA vaccines BNT162b2 and mRNA-1273 have played a key role in our global response to the COVID-19 pandemic as they have demon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akamine, Christine M., El Sahly, Hana M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695521/ https://www.ncbi.nlm.nih.gov/pubmed/34954088 http://dx.doi.org/10.1016/j.trsl.2021.12.007

Ejemplares similares

Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 Messenger Ribonucleic Acid Vaccines in Infected Individuals: A Systematic Review
por: Roslan, Madihah, et al.
Publicado: (2023)

Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents
por: Schauer, Jenna, et al.
Publicado: (2021)

Acute encephalomyelitis in a 52-year-old male post messenger ribonucleic acid severe acute respiratory syndrome coronavirus 2 vaccination: a case report
por: Alebna, Pamela Lamisi, et al.
Publicado: (2023)

Fulminant Myocarditis 24 Days after Coronavirus Disease Messenger Ribonucleic Acid Vaccination
por: Kawano, Hiroaki, et al.
Publicado: (2022)

Humoral and cellular immune response after severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccination in heart transplant recipients: An observational study in France
por: Casenaz, Alice, et al.
Publicado: (2022)

Effectiveness of Messenger Ribonucleic Acid Vaccine in Lung Transplant Recipients
por: Vender, R.J., et al.
Publicado: (2022)

Bilateral Axillo-Brachial Artery Stenosis Following Messenger Ribonucleic Acid (mRNA) Vaccination Against Severe Acute Respiratory Coronavirus 2 (COVID-19)
por: Güven, Hasan
Publicado: (2023)

Long-term evaluation of sperm parameters after coronavirus disease 2019 messenger ribonucleic acid vaccination
por: Diaz, Parris, et al.
Publicado: (2022)

Stress induced by messenger ribonucleic acid (RNA) vaccination may reveal acute adrenal insufficiency
por: Mariette, C., et al.
Publicado: (2021)

Messenger ribonucleic acid vaccine-associated immune thrombocytopenia: A rare complication of vaccine
por: Islamoglu, Mehmet Sami, et al.
Publicado: (2022)

Diagnostics of messenger ribonucleic acid (mRNA) severe acute respiratory syndrome-corona virus‑2 (SARS-CoV‑2) vaccination-associated myocarditis—A systematic review
por: Federspiel, Jan M., et al.
Publicado: (2022)

Validation of Messenger Ribonucleic Acid Markers Differentiating Among Human Acute Respiratory Distress Syndrome Subgroups in an Ovine Model of Acute Respiratory Distress Syndrome Phenotypes
por: Wildi, Karin, et al.
Publicado: (2022)

Messenger ribonucleic acid vaccines against infectious diseases: current concepts and future prospects
por: Edwards, Darin K, et al.
Publicado: (2022)

Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review
por: Yihunie, Wubetu, et al.
Publicado: (2023)

Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine
por: Watts, Melissa M., et al.
Publicado: (2022)

Inherited Retinal Disease Therapies Targeting Precursor Messenger Ribonucleic Acid
por: Huang, Di, et al.
Publicado: (2017)

A Case of Autoimmune Hemolytic Anemia Following COVID-19 Messenger Ribonucleic Acid Vaccination
por: Brito, Sérgio, et al.
Publicado: (2021)

An 88-year-old woman with acute disseminated encephalomyelitis following messenger ribonucleic acid-based COVID-19 vaccination
por: Shimizu, Mai, et al.
Publicado: (2021)

Side effects and antibody titer transition of the BNT162b2 messenger ribonucleic acid coronavirus disease 2019 vaccine in Japan
por: Izumo, Takehiro, et al.
Publicado: (2021)

Cap-dependent translation without base-by-base scanning of an messenger ribonucleic acid
por: Paek, Ki Young, et al.
Publicado: (2012)

Messenger RNA vaccines and neutralizing anti–severe acute respiratory syndrome coronavirus 2 antibodies in patients with immunodeficiency
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization After Messenger RNA Vaccination and Variant Breakthrough Infection
por: Gaebler, Christian, et al.
Publicado: (2022)

Long-term positive severe acute respiratory syndrome coronavirus 2 ribonucleic acid and therapeutic effect of antivirals in patients with coronavirus disease: Case reports
por: Wei, Bo, et al.
Publicado: (2020)

Comprehensive Assessment of BARD1 Messenger Ribonucleic Acid Splicing With Implications for Variant Classification
por: Walker, Logan C., et al.
Publicado: (2019)

Anatomical Site, Viral Ribonucleic Acid Abundance, and Time of Sampling Correlate With Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 During Infection
por: Lantry, F Julian, et al.
Publicado: (2021)

Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 Vaccine( )
por: Maron, Jenny S, et al.
Publicado: (2022)

SYNTHESIS OF MESSENGER-LIKE RIBONUCLEIC ACID AND PROTEIN DURING MEIOSIS IN ISOLATED CELLS OF TRILLIUM ERECTUM
por: Hotta, Yasuo, et al.
Publicado: (1963)

Multiple Autoimmune Syndromes Including Acute Disseminated Encephalomyelitis, Myasthenia Gravis, and Thyroiditis Following Messenger Ribonucleic Acid-Based COVID-19 Vaccination: A Case Report
por: Poli, Khouloud, et al.
Publicado: (2022)

Longitudinal Neutralizing and Functional Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants Following Messenger RNA Coronavirus Disease 2019 Vaccination
por: Chen, Xuemin, et al.
Publicado: (2023)

Enzymatic Protein Biopolymers as a Tool to Synthetize Eukaryotic Messenger Ribonucleic Acid (mRNA) with Uses in Vaccination, Immunotherapy and Nanotechnology
por: Urbina, Fabiola, et al.
Publicado: (2020)

Hyperinflammatory Syndromes After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Messenger RNA vaccination in Individuals With Underlying Immune Dysregulation
por: Rocco, Joseph M, et al.
Publicado: (2021)

Association of Frailty, Age, and Biological Sex With Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine–Induced Immunity in Older Adults( )
por: Shapiro, Janna R, et al.
Publicado: (2022)

Circulating thyrotropin receptor messenger ribonucleic acid is not an effective marker in the follow-up of differentiated thyroid carcinoma
por: Ausavarat, Surasawadee, et al.
Publicado: (2015)

Assessment Effects of Resveratrol on Human Telomerase Reverse Transcriptase Messenger Ribonucleic Acid Transcript in Human Glioblastoma
por: Mirzazadeh, Azin, et al.
Publicado: (2017)

Severe acute respiratory syndrome coronavirus 2 antibody response to a third dose of homologous messenger RNA vaccination in liver transplantation recipients
por: Strauss, Alexandra T., et al.
Publicado: (2022)

Upper Respiratory Tract Viral Ribonucleic Acid Load at Hospital Admission Is Associated With Coronavirus Disease 2019 Disease Severity
por: Guo, Xiaoyan, et al.
Publicado: (2020)

Failure to Detect Viral Ribonucleic Acid in Follicular Fluid of a Severe Acute Respiratory Syndrome Coronavirus 2-Infected Female – A Report from the Indian Subcontinent
por: Bhayana, Dhir Pooja, et al.
Publicado: (2022)

The ribonucleic acids
Publicado: (1977)

Messenger ribonucleic acid expression of KiSS-1 and serum level of kisspeptin in rat at different developmental stages
por: Ahn, Jung Min, et al.
Publicado: (2015)

Comparison of Endoplasmic Reticulum Stress Messenger Ribonucleic Acid Expression Between Chronic Otitis Media With and Without Cholesteatoma
por: Woong Kang, Dae, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2saj2tt1ngfa88tjo24bd9b10r